undamentalytics Newsletter
Sign in

Skinhealth Systems Inc. key statistics and ratios

In fiscal 2025, Skinhealth Systems Inc. had return on equity of -16.9%, an operating margin of -6.9%, debt equal to 596.8% of equity and a current ratio of 1.66. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Gross margin63.9%56.4%68.6%68.0%39.0%54.5%65.3%66.4%
Operating margin8.1%−14.4%−15.4%−7.1%−32.9%−20.3%−6.9%−1.5%
Net margin−1.0%−24.5%−145.6%12.1%−25.2%−8.7%−3.2%−9.8%
Free-cash-flow margin−4.2%−13.4%−15.2%−32.1%4.5%4.6%12.4%7.3%
Return on equity———19.0%−88.4%−52.3%−16.9%−48.8%
Return on assets—−13.1%−52.5%4.0%−10.4%−3.6%−1.6%−5.8%
Asset turnover—0.530.360.330.410.410.510.59
Current ratio—1.9113.0910.926.077.001.661.76
Debt to equity——244.9%439.5%>999%>999%596.8%621.2%
Interest cover (operating income ÷ interest)——n/mn/mn/mn/mn/mn/m
Effective tax rate———2.5%————
R&D as % of revenue2.8%2.9%3.2%2.3%2.5%1.9%1.9%2.0%
Capital spending as % of revenue5.3%2.9%4.3%3.0%1.0%0.2%0.1%0.3%
Free cash flow ÷ net income———−265.6%————
Dividends and buybacks ÷ free cash flow————168.2%0.0%0.0%—

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

2 of 3 checks passed · June 30, 2026
What it owns · $487m
Short-term assets $295mLonger-term assets $191m
What it owes, and who funded it · $487m
Short-term liabilities $168mLonger-term liabilities $263mShareholders' equity $56m
  • Short-term assets cover short-term liabilities $295m of assets due within a year against $168m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $295m short-term assets against $263m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Operating income of −$4m against $25m of interest.

From Skinhealth Systems Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

34 /100

Weak moat

How hard Skinhealth Systems's competitive advantage looks for rivals to wear away, judged from 6 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Cash operating profit has been a median -7.0% of total assets over 5 years.

  • Pricing power 12 / 20

    Gross margin has been a median 64.9%, moving by 12.0 percentage points (standard deviation) across 6 years.

  • Durability 10 / 20

    Operating margin has been a median -12.3%; its worst year was -38.1%.

  • Cash conversion 5 / 20

    Free cash flow was positive in 3 of 6 years, at a median -4.5% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: AXGN vs SKINKIDS vs SKINLMAT vs SKIN

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Skinhealth Systems Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Skinhealth Systems Inc.